Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep866 | Thyroid cancer | ECE2015

Serum Galectin-3 in papillary thyroid cancer: preliminary results

Caragheorgheopol Andra , Schipor Sorina , Manda Dana , Stefanescu Ana-Maria , Ioachim Dumitru , Badiu Corin

Background: There are only few reports regarding the role of serum galectin-3 (Gal-3) as an early biochemical marker in thyroid carcinoma.Aim: To evaluate the potential overexpression of Gal-3 in sera from patients with confirmed diagnosis of papillary thyroid carcinoma (PTC).Patients and methods: We retrospectively investigated serum Gal-3 in 40 patients referred to the surgical department for thyroidectomy. Sera were collected be...

ea0037ep1278 | Clinical Cases–Thyroid/Other | ECE2015

Autoimmune polyglandular syndrome: case report series

Nan Raluca , Guja Cristian , Caragheorgheopol Andra , Manda Dana , Radulian Gabriela , Musat Madalina

Introduction: The polyglandular autoimmune syndromes (PAS) are rare conditions characterised by the failure of several endocrine glands sometimes associated with other non-endocrine autoimmune diseases. There are four categories of PAS: PAS-I includes at least two out of: mucocutaneous candidiasis, hypoparathyroidism and adrenocortical failure. PAS-II comprises of Addison’s disease, autoimmune thyroid disease and/or type 1 diabetes (Carpenter’s syndrome). PAS-III is ...

ea0035p612 | Endocrine tumours and neoplasia | ECE2014

Metabolic and cardiovascular complications in patients with adrenal incidentalomas

Gheorghiu Monica Livia , Voicu Alina , Caragheorgheopol Andra , Coculescu Mihai , Poiana Catalina

Introduction: We evaluated the prevalence of metabolic and cardiovascular complications in a Romanian population with adrenal incidentalomas in comparison with an age-matched control group, evaluated in our clinic.Patients and methods: After excluding patients with overt functioning adrenal tumors, subclinical pheochromocytomas, malignant tumors, myelolipomas, data were retrieved from the files of 190 patients with adrenal incidentalomas ≥1 cm and ...

ea0035p799 | Paediatric endocrinology | ECE2014

Vitamin D assessment in infants with prolonged hospitalisation

Ardeleanu Ioana Sonia , Delia Corina Elena , Berghes Felicia , Padure Adriana , Manda Dana , Caragheorgheopol Andra

Background: Vitamin D deficiency – a common condition in infants without supplementation – leads to a variety of health impairments.Objectives: To assess 25-OH-vitamin D (VD) status in infants with prolonged hospitalisation, without direct exposure to sunlight.Materials and methods: Twenty-two infants (mean age 6 years 3 months), admitted into Recuperation Department of a Children Hospital for nutritional rehabilitation, ...

ea0070aep75 | Adrenal and Cardiovascular Endocrinology | ECE2020

Differential diagnosis of primary adrenal insufficiency in a young male with mental retardation and axonal sensorimotor polyneuropathy

Cristina Baleanu Maria , Galoiu Simona , Popa Lavinia , Margarit Emma , Constantin Marinescu Mihai , Caragheorgheopol Andra , Poiana Catalina

Introduction: Primary adrenal insufficiency (PAI) is a rare disease with a prevalence of 82–144 cases/milion. The etiology of PAI is represented primarily by autoimmune adrenalitis, followed by tuberculosis and less common by fungal infections, HIV, hemorrage in adrenal glands, certain drugs and by some genetic disorders such as Triple A syndrome (AAA), Adrenoleukodystrophy (ALD), congenital adrenal hypoplasia, congenital adrenal hyperplasia, etc.C...

ea0070aep580 | Pituitary and Neuroendocrinology | ECE2020

Real life efficiency of pegvisomant therapy in acromegaly

Maria Lider Burciulescu Sofia , Livia Gheorghiu Monica , Caragheorgheopol Andra , Purice Mariana , Badiu Corin

Introduction: Pegvisomant (PEG) is an efficient treatment for acromegaly but the recommendation for this treatment is less active due to its high cost. In Romania it is reimbursed in doses up to 30 mg s.c/day or as 40 or 80 mg/week in combination with a somatostatin analog (SSA).Design: Retrospective analysis of 18 consecutive patients treated with PEG for acromegaly (either as monotherapy, or in combination with SSA and/or cabergoline (CAB...

ea0070aep925 | Thyroid | ECE2020

Basal and stimulated calcitonin: Different experience on liaison and cobas assays

Băetu Mara , Drăghici Alexandru , Pădure Adriana , Caragheorgheopol Andra , Badiu Corin

Introduction: The determination of basal and stimulated calcitonin (CT) is very important for the precocious diagnosis of medullary thyroid carcinoma (MTC) and for its dynamic follow-up. Unfortunately, monitoring is difficult when using assays with different detection systems. Our objective was to identify the correction factor between the reagents for CT measurement on the LiaisonXL and Cobase 601 assays (immunochemiluminescence, respectively electro-immunochemiluminescence)....

ea0070aep945 | Thyroid | ECE2020

MMP-9 1562 C/T polymorphism may be associated with an increased susceptibility to develop micropapillary thyroid cancer but not more advanced tumours

Dobrescu Ruxandra , Schipor Sorina , Picu Catalina , Manda Dana , Caragheorgheopol Andra , Badiu Corin

Background: Matrix metalloproteinase-9 (MMP-9) is an important mediator of invasion and metastasis in neoplasia. The single nucleotide 1562 C/T polymorphism in the promoter region of the MMP-9 genewas shown to increase gene expression and was studied as a susceptibility factor for various cancers.Aim: We aimed to evaluate the impact of the MMP-9 promoter genotype on the risk of developing papillary thyroid cancer (PTC) and to correlate cancer patient gen...

ea0070ep54 | Adrenal and Cardiovascular Endocrinology | ECE2020

Cortisol and androgens secreting left adrenal carcinoma

Margarit Emma , Simona Andreea Găloiu , Dumitrascu Anda , Caragheorgheopol Andra , Beuran Mircea , Poiana Catalina

Introduction: Adrenal carcinomas are rare tumor. It has an estimated incidence of ~0.5–2 new cases per million people per year. Just 25% of adults with hormone-secreting adrenal carcinomas present overproduction of both glucocorticoids and androgens. Women develop adrenal carcinomas more often than men.Objectives: We report a case of 47-year-old female presented with weight gain, generalized weakness and hypertension for the last 6 months. Phy...

ea0070ep270 | Endocrine-related Cancer | ECE2020

All with men 2A in one family?

Lazar Diana-Georgiana , Vasilescu Sorana L. , Elena Oros Sabina , Dumitrascu Anda , Smarandache Romeo , Caragheorgheopol Andra

Multiple endocrine neoplasya type 2 (MEN-2) is a rare hereditary complex disorder caused by a germline activating mutation of the RET proto-oncogene. The estimated prevalence is approximately 1:30.000. Three clinical forms have been described depending on the phenotype: MEN2A (80%), MEN2B and familial medullary thyroid carcinoma (MTC).Clinically, MEN2A present with MTC (80–100%), unilateral or bilateral pheocromocytoma (40%) and primary hyperparath...